ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Funds and ETFs Zhejiang Huahai Pharmaceutical Co., Ltd.
Equities
600521
CNE000001DL5
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.11 CNY | +0.37% |
|
+2.55% | +9.82% |
| Apr. 29 | Zhejiang Huahai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 24 | Huahai Pharmaceutical Gets Approval to Market Busulfan Injection | MT |
ETFs positioned on Zhejiang Huahai Pharmaceutical Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.57% | 2 M€ | -14.86% | - | |
| 0.01% | 117 M€ | +1.54% | - | |
| 0.00% | 4 M€ | -4.41% | - | |
| 0.00% | 2,808 M€ | +6.17% | - | |
| 0.00% | 441 M€ | +5.00% | - | |
| 0.00% | 149 M€ | +3.21% | - | |
| 0.00% | 31 M€ | +4.15% | - | |
| 0.00% | 7 M€ | +2.68% | - | |
| 0.00% | 389 M€ | +6.81% | - | |
| 0.00% | 147 M€ | +4.88% | - | |
| 0.00% | 34 M€ | +2.43% | - | |
| 0.00% | 108 M€ | +2.01% | - | |
| 0.00% | 52 M€ | -0.30% | - | |
| 0.00% | 15 M€ | +13.33% |
ZHEJIANGHUAHAIPHARMACEUTICALCO., LTD is a China-based company, principally engaged in the manufacture and distribution of active pharmaceutical ingredients (APIs), intermediates and preparations. The Company's main products are classified as -pril series, -sartan series and preparations, including irbesartan tablets, paroxetine hydrochloride tablets, risperidone tablets, fosinopril sodium tablets, as well as irbesartan and hydrochlorothinzide tablets, among others. The Company also provides related technical support services. The Company distributes its products in domestic and overseas markets.
Sector
Pharmaceuticals
Calendar
Apr. 28
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
16.11
CNY
Average target price
16.37
CNY
Spread / Average Target
+1.59%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +9.82% | 3.28B | |
| +26.47% | 664B | |
| +28.33% | 567B | |
| -6.33% | 354B | |
| +19.35% | 330B | |
| +4.23% | 286B | |
| +13.68% | 234B | |
| +4.93% | 199B | |
| -10.06% | 196B | |
| -4.04% | 148B |
- Stock Market
- Equities
- 600521 Stock
- Funds and ETFs Zhejiang Huahai Pharmaceutical Co., Ltd.
